Amicus Therapeutics, Inc. Enters Oversold Territory - Tale of the Tape

By
A A A

Amicus Therapeutics, Inc. 's ( FOLD ) share price has entered into oversold territory with an RSI value of 29.7. The Zacks Consensus Estimate on Amicus Therapeutics, Inc.'s earnings for the full year period has loss of 0.00 cents over the past two months to $-1.30 per share. Currently, Amicus Therapeutics, Inc. is a Zacks #2 Rank ("Buy"), suggesting that now might be a good time to get in on ( FOLD ) after its recent drop.

AMICUS THERAPT (FOLD): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: FOLD

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

GeneralPencil_USETBASITE
GeneralPencil_USETBASITE            

Stocks

Referenced

Most Active by Volume

61,534,929
  • $46.82 ▲ 21.33%
23,752,760
  • $15.40 ▲ 0.39%
21,234,986
  • $3.45 ▲ 1.47%
16,838,568
  • $29.205 ▼ 0.90%
15,418,039
  • $7.865 ▼ 1.69%
15,391,389
  • $36.44 ▲ 2.13%
14,923,796
  • $74.76 ▲ 1.42%
14,555,615
  • $32.695 ▲ 18.16%
As of 7/30/2014, 11:19 AM